Gynecologic Cancer

Top Story

Experts reveal ‘troubling’ industry-employed strategies to delay availability of generic cancer drugs

Experts reveal ‘troubling’ industry-employed strategies to delay availability of generic cancer drugs
February 8, 2016

Pharmaceutical companies have employed several strategies — including reverse payment, patent settlements and “product hopping” — to prevent affordable generic cancer drugs from entering the market, according to a forum article published in Blood.

These tactics also have led to an increase in drug prices so that, if available, generics can cost nearly as much as the branded product.

In the Journals

Racial, treatment-related factors may influence bevacizumab efficacy in advanced cervical cancer

February 7, 2016
Use of Moore criteria may identify patients with advanced cervical cancer who may not benefit from treatment with bevacizumab, according to results of a study conducted…
In the Journals

World Cancer Day: ‘We can’ reduce global cancer burden

February 4, 2016
Today marks the annual observation of World Cancer Day, founded by the Union for International Cancer Control to raise awareness of cancer and emphasize the importance…
FDA News

FDA grants fast track designation to TPIV 200 for ovarian cancer

February 3, 2016
The FDA today granted fast track designation to TPIV 200 for the treatment of ovarian cancer, according to a press release.TPIV 200 (TapImmune Inc.) — a multiple…
CME

The Patient with Severe Leukocytosis

No commercial support for this activity.

Currently five tyrosine kinase inhibitors are available for use in patients with chronic myeloid leukemia (CML)…
More »
Meeting News CoverageVideo

Antibody-drug conjugate shows promise for NSCLC, ovarian cancer

June 12, 2014
More »
Featured
CME

The Patient with Myelofibrosis

No commercial support for this activity.

Myelofibrosis is caused by abnormal stem cells in the bone marrow that cause the uncontrolled production of mature…
More »
In the Journals

Experts reveal ‘troubling’ industry-employed strategies to delay availability of generic cancer drugs

February 8, 2016
Pharmaceutical companies have employed several strategies — including reverse payment, patent settlements and “product hopping”…
In the Journals

Racial, treatment-related factors may influence bevacizumab efficacy in advanced cervical cancer

February 7, 2016
Use of Moore criteria may identify patients with advanced cervical cancer who may not benefit from treatment with bevacizumab, according to results…
In the Journals

World Cancer Day: ‘We can’ reduce global cancer burden

February 4, 2016
Today marks the annual observation of World Cancer Day, founded by the Union for International Cancer Control to raise awareness of cancer and…
FDA News

FDA grants fast track designation to TPIV 200 for ovarian cancer

February 3, 2016
The FDA today granted fast track designation to TPIV 200 for the treatment of ovarian cancer, according to a press release.TPIV 200 (TapImmune Inc.)…

Memorial Sloan Kettering program focuses on cancer disparities among U.S. immigrants

February 1, 2016
Immigrants are considerably underserved in terms of health care in the United States. Memorial Sloan Kettering Cancer Center launched its Immigrant…
In the Journals

Lavage technique may detect early-stage ovarian, endometrial cancers

January 31, 2016
Tumor cells from shed ovarian neoplasms can be collected through lavage of the uterine cavity, according to the results of a proof-of-concept…
In the Journals

Bankruptcy increases risk for cancer mortality

January 28, 2016
Filing for bankruptcy protection after a cancer diagnosis appeared associated with an increased risk for death, according to the results of a…
Breaking News

NCI-designated cancer centers call for increase in HPV vaccination

January 27, 2016
Sixty-nine NCI-designated cancer centers today issued a call for action to urge an increase in HPV vaccination rates for the prevention of cancer.The…

ORIEN precision cancer initiative designed to do what no single center can achieve alone

January 26, 2016
The Oncology Research Information Exchange Network precision cancer research collaboration has added three new partners to the team: Rutgers Cancer…

MD Anderson's Moon Shots program expands into new cancer types

January 25, 2016
Originally launched in 2013, The University of Texas MD Anderson Cancer Center’s Moon Shots Program recently expanded its campaign to…
More Headlines »
morganatic-roan